Drug Shortages Reveal GMP Concerns

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-06-02-2002, Volume 26, Issue 6

FDA cites manufacturing difficulties as a main contributing factor to recent drug shortages, which mainly involve injectibles and vaccines.

Related Content:

Regulatory/GMP ComplianceQuality SystemsRegulatory WatchPharmaceutical Technology-06-02-2002
PTC Therapeutics Gains FDA Approval for AADC Deficiency Gene Therapy
EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease
J&J’s Balversa Gains MHRA Marketing Authorization as Monotherapy for Bladder Cancer